Evidence map›Paper›PMID 41886634›Full record

ArticleJournal of global health2026

A comparative study of incidence rate and severity of influenza virus and respiratory syncytial virus associated hospitalisation in older adults in Jiangsu Province, China: a retrospective analysis of a regional medical database.

Tiantian Zhang, Ling Guo, Yumeng Miao, Caini Wang, Xin Wang, You Li

Abstract readComparative Study
In one paragraph

Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tiantian ZhangDepartment of Epidemiology, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, China.
Ling GuoDepartment of Epidemiology, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, China.
Yumeng MiaoDepartment of Epidemiology, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, China.
Caini WangDepartment of Epidemiology, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, China.
Xin WangDepartment of Epidemiology, School of Public Health, Key Laboratory of Public Health Safety and Emergency Prevention and Control Technology of Higher Education Institutions in Jiangsu Province, Nanjing Medical University, Nanjing, China.
You LiDepartment of Epidemiology, National Vaccine Innovation Platform, School of Public Health, Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Few studies have compared the disease burden between influenza virus (IFV) and respiratory syncytial virus (RSV) in older adults, particularly outside high-income countries. We aimed to compare IFV- and RSV-associated hospitalisation burden and severity in older adults in Jiangsu Province, China. Methods: Drawing on a medical database from Jiangsu Province, an economically-developed province in eastern China, we included acute respiratory infections (ARI) admission records in adults aged ≥60 years during 2020 to 2023, linked with viral testing data, where available. We applied a time-series regression model for estimating RSV- and IFV-associated hospitalisation rates by year, age group, and sex. We compared disease severity, defined as a composite of mechanical ventilation use, intensive care unit (ICU) admission, or in-hospital mortality, between RSV- and IFV-positive cases using multivariable logistic regression, with adjustments for age, sex, year, region, and laboratory method. Results: We included 188 529 ARI hospitalisation episodes during the study period. RSV and IFV had comparable hospitalisation rates, peaking in 2023 at 98 per 100 000 person-years (95% confidence interval (CI) = 81-115) for RSV and 116 per 100 000 person-years (95 CI = 100-133) for IFV. Hospitalisation rates increased with older age and were marginally higher in males. The risk for severe cases was 1.47 (95% CI = 1.086-1.997, P = 0.013) times higher in RSV than in IFV. Older age and being males were independent risk factors for severe cases. Conclusions: We found the RSV hospitalisation burden to be comparable to that of IFV in older adults, albeit with higher severity. The findings contribute to the evidence base for recommendation of RSV and IFV vaccination in older adults in China.

Indexed as

HospitalizationInfluenza, HumanRespiratory Syncytial Virus InfectionsAgedAged, 80 and overChinaDatabases, FactualFemaleHumansIncidenceMaleMiddle AgedRetrospective StudiesSeverity of Illness Index

Identifiers

PMID41886634
PMCPMC13021056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.